We appreciate the letter from Johnson and Gould providing further information on their analysis software that enables quantification of myocardial blood flow based on retention kinetics and simplified acquisition protocol as compared with methods using compartmental modeling. The limitation of that software is that it currently allows analysis of data produced only by scanners manufactured by a single vendor. In addition, although the users have been apparently positive in their comments, rigorous direct comparison of this software against the others would be needed to judge, which method or software is better than the other.
We very much appreciate that the authors have earlier presented an algorithm for interpreting absolute flow and flow reserve data in clinical decision making. 1 Such integrative algorithms are necessary for trials of revascularization guided by absolute flow measurements. Meanwhile, more studies have shown that noninvasive quantitative assessment of coronary vasodilator function with positron emission tomography is a powerful, independent predictor of cardiac mortality. Data from a large patient cohort of 2,783 patients with known or suspected coronary artery disease demonstrated the incremental prognostic value of flow reserve over semi-quantitative measures of myocardial ischemia and scar as well as other clinical variables for identification of patients at risk of cardiac death. 2 The addition of flow reserve resulted in the correct reclassification of approximately one-third of all intermediate-risk patients. Another study provided evidence that among diabetic patients without coronary artery disease, those with impaired flow reserve had event rates comparable to patients with prior coronary artery disease while those with preserved flow reserve had event rates comparable to non-diabetics. 
